KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Net Margin (2016 - 2025)

Historic Net Margin for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 2.15%.

  • Biogen's Net Margin fell 130100.0% to 2.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.07%, marking a year-over-year decrease of 38000.0%. This contributed to the annual value of 13.07% for FY2025, which is 38000.0% down from last year.
  • Latest data reveals that Biogen reported Net Margin of 2.15% as of Q4 2025, which was down 130100.0% from 18.4% recorded in Q3 2025.
  • In the past 5 years, Biogen's Net Margin registered a high of 45.59% during Q3 2022, and its lowest value of 4.85% during Q3 2021.
  • For the 5-year period, Biogen's Net Margin averaged around 15.56%, with its median value being 16.26% (2021).
  • As far as peak fluctuations go, Biogen's Net Margin skyrocketed by 504400bps in 2022, and later plummeted by -481300bps in 2023.
  • Over the past 5 years, Biogen's Net Margin (Quarter) stood at 3.72% in 2021, then skyrocketed by 691bps to 21.97% in 2022, then crashed by -53bps to 10.43% in 2023, then rose by 4bps to 10.86% in 2024, then plummeted by -120bps to 2.15% in 2025.
  • Its Net Margin stands at 2.15% for Q4 2025, versus 18.4% for Q3 2025 and 24.0% for Q2 2025.